1[1]Braunwald E, Califf RM, Cannon CP, et al. Redefining medical treatment in the management of unstable Angina[J]. Am J Med, 2000,108:41.
2[2]Yamashito K, Ouchi K, Shirai M, et al. Distribution of chlamydia pneumonia infection in the atherosclerotic carotic artery[J]. Stroke, 1998,29:773.
3[3]Mehta JL, Saldeen TG, Rand K. Interaction role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease[J]. J Am Coll Cardiol, 1998,31:1217.
4[4]Jerffery L, Anderson MD, Facc JF, et al. Evaluation of C-reactive protein, an inflammatory marker and infectious serology as risk factors for coronary disease and myocardial infaction[J]. J Am Coll Cardiol, 1998,32:35.
5[5]Tataru MC, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J, 2000,21:1000.
6[6]Oltrona L, Ardissino D,Merlini PA, et al. C-reactive protein elevation and early outcome in patients with unstable angina pectoris[J]. Am J Cardiol, 1997,80:1002.
7[1]Alexander RW.Inflammation and coronary artery disease [J].N Engl J Med,1994,331:468-469.
8[2]Torzewski J,T orzewski M,Bowyer DE,et al.C-reative protein frequently colocalizes with the terminal comlement complex in the intima of early atherosclerotic lesions of human coronary arteries [J].Arterioscler Thromb Vasc Biol,1998,18:1386-1392.
9[3]Reynolds GD,Vance RP.C-reative protein immunohistochemical localization in normal and atherosclerotic human aortas [J].Arch Pathol Lab Med,1987,111:26.
